Johnson & Johnson coronavirus vaccine trial pause 'quite common,' Alex Azar says
The pause on Johnson & Johnson’s coronavirus vaccine research study, which is due to an adverse reaction by one of the participants, is “quite common” in vaccine clinical trials, Health and Human Services Secretary Alex Azar told “Varney & Co.” on Tuesday.
via DigioNews Markets
Note : I Hope My My New News Article : Johnson & Johnson coronavirus vaccine trial pause 'quite common,' Alex Azar says Of DigioNews So You Trust My site you are always updated with Latest news Daily news Everyday. Only on DigioNews : Johnson & Johnson coronavirus vaccine trial pause 'quite common,' Alex Azar says
0 Comments